Immunitybio Inc 's ability to collect accounts receivable sequentially worsen to 3.87, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Immunitybio Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 94 days, from 91 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 435 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 2205 to 2927.

What is Receivable Turnover Ratio?
What is Immunitybio Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

IBRX Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	139.46 %	147.95 %	1506.37 %	553.22 %	983.98 %
Y / Y Revenue Change	93.91 %	167.64 %	406.95 %	425.07 %	2423.88 %
Receivable Turnover Ratio (TTM)	3.87	4.02	3.96	4.43	4.78
IBRX's Total Ranking	# 2927	# 2205	# 2653	# 2667	# 1825
Accounts Receivable average collection period days	94	91	92	82	76
Seq. Receivable Change	23.57 %	1.54 %	33.04 %	43.46 %	27.94 %
Seq. Revenue Change	15.91 %	15.47 %	19.41 %	21.33 %	59.99 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 47
Healthcare Sector	# 436
Overall Market	# 2927

Receivable Turnover Ratio Statistics
High	Average	Low
5.02	1.27	0.11
(Dec 31 2024)		(Dec 31 2022)

IBRX Company Profile • Back to IBRX Efficiency Comparisons • Compare IBRX Receivables Turnover Ratio to its Competitors

Financial Statements
Immunitybio Inc 's Accounts Receivable	$ 53 Millions	Visit IBRX's Balance sheet
Immunitybio Inc 's Sales TTM	$ 166 Millions	Visit IBRX's Income Statement
Sources of IBRX's Revenues		Visit IBRX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
IBRX's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
IBRX's Growth Rates	IBRX's Roa	IBRX's Inventory Turnover Ratio	IBRX's Dividend Comparisons
IBRX's Profitability Ratios	IBRX's Roi	IBRX's Asset Turnover Ratio	IBRX's Dividend Growth
IBRX's Valuation Ratios	IBRX's Roe	IBRX's Financial Strength Ratios	IBRX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Volitionrx Limited	8.50	$ 2.458 Millions	$ 0.289 Millions
Ensign Group Inc	8.50	$ 5,486.708 Millions	$ 645.470 Millions
Inogen Inc	8.47	$ 354.304 Millions	$ 41.817 Millions
Axogen inc	8.42	$ 251.174 Millions	$ 29.846 Millions
Rockwell Medical inc	8.31	$ 69.827 Millions	$ 8.400 Millions
Sonoma Pharmaceuticals Inc	8.24	$ 21.920 Millions	$ 2.661 Millions
Adapthealth Corp	8.14	$ 3,226.709 Millions	$ 396.643 Millions
Seastar Medical Holding Corp	8.11	$ 1.713 Millions	$ 0.211 Millions
Atricure Inc	8.08	$ 567.747 Millions	$ 70.232 Millions
Concentra Group Holdings Parent Inc	8.07	$ 2,287.465 Millions	$ 283.300 Millions
Sanuwave Health Inc	8.04	$ 43.903 Millions	$ 5.461 Millions
Aveanna Healthcare Holdings Inc	8.03	$ 2,602.820 Millions	$ 324.026 Millions
Sotera Health Company	8.01	$ 1,215.925 Millions	$ 151.745 Millions
Avita Medical Inc	7.99	$ 75.631 Millions	$ 9.463 Millions
Alphatec Holdings Inc	7.94	$ 814.780 Millions	$ 102.662 Millions
Tenet Healthcare Corp	7.92	$ 21,812.000 Millions	$ 2,752.500 Millions
Henry Schein Inc	7.91	$ 13,602.000 Millions	$ 1,719.000 Millions
Tela Bio Inc	7.86	$ 80.535 Millions	$ 10.243 Millions
Pacs Group Inc	7.78	$ 5,551.038 Millions	$ 713.483 Millions
Vycor Medical Inc	7.68	$ 1.807 Millions	$ 0.235 Millions
Idexx Laboratories Inc	7.65	$ 4,553.792 Millions	$ 595.549 Millions
Sharps Technology Inc	7.65	$ 2.468 Millions	$ 0.323 Millions
Natera Inc	7.61	$ 2,707.077 Millions	$ 355.618 Millions
Quest Diagnostics Inc	7.56	$ 11,560.000 Millions	$ 1,529.250 Millions
Fortress Biotech Inc	7.55	$ 69.983 Millions	$ 9.266 Millions
Protalix Biotherapeutics inc	7.55	$ 80.619 Millions	$ 10.677 Millions
Iridex Corp	7.49	$ 51.044 Millions	$ 6.816 Millions
Novocure Limited	7.46	$ 699.193 Millions	$ 93.686 Millions
Intuitive Surgical Inc	7.46	$ 11,296.300 Millions	$ 1,513.950 Millions
Transmedics Group Inc	7.43	$ 668.468 Millions	$ 89.962 Millions

Date modified: 2026-08-30T21:40:58+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.